Jojima T, Uchida K, Akimoto K, Tomotsune T, Yanagi K, Iijima T, Suzuki K, Kasai K, Aso Y: Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice
its a metabolically active organ that triggers systemic inflammation
By activating special receptors in hypothalamus and brainstem it can influence the regulation of the sleep cycle resulting in enhancing deep sleep and minimizing insomnia and anxiety
Recording injection locations in a simple log or phone app prevents accidentally using the same area too frequently
Think of these junctions like the grout between tiles
Extraintestinal manifestations of inflammatory bowel disease [in German]